Cargando…
The dual role and therapeutic potential of high-mobility group box 1 in cancer
High-mobility group box 1 (HMGB1) is an abundant protein in most eukaryocytes. It can bind to several receptors such as advanced glycation end products (RAGE) and Toll-like receptors (TLRs), in direct or indirect way. The biological effects of HMGB1 depend on its expression and subcellular location....
Autores principales: | He, Si-Jia, Cheng, Jin, Feng, Xiao, Yu, Yang, Tian, Ling, Huang, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610024/ https://www.ncbi.nlm.nih.gov/pubmed/28969092 http://dx.doi.org/10.18632/oncotarget.17885 |
Ejemplares similares
-
High mobility group box-1: a potential therapeutic target for allergic rhinitis
por: Wu, Shuhua, et al.
Publicado: (2023) -
Role of High-Mobility Group Box-1 in Liver Pathogenesis
por: Khambu, Bilon, et al.
Publicado: (2019) -
Pivotal neuroinflammatory and therapeutic role of high mobility group box 1 in ischemic stroke
por: Richard, Seidu A., et al.
Publicado: (2017) -
The Role of High Mobility Group Box 1 in Ischemic Stroke
por: Ye, Yingze, et al.
Publicado: (2019) -
High-mobility group box 1: role in ARDS
por: Ishizaka, A, et al.
Publicado: (2005)